EDGAR Filing Documents for 0001214659-15-005948

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001214659-15-005948

Filing Date

2015-08-10

Accepted

2015-08-10 16:31:13

Documents

Period of Report

2015-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2015	a8715010.htm	10-Q	972891
2	EXHIBIT 3.4	ex3_4.htm	EX-3.4	143200
3	EXHIBIT 10.1	ex10_1.htm	EX-10.1	11479
4	EXHIBIT 31.1	ex31_1.htm	EX-31.1	16497
5	EXHIBIT 31.2	ex31_2.htm	EX-31.2	16698
6	EXHIBIT 32.1	ex32_1.htm	EX-32.1	6220
7	EXHIBIT 32.2	ex32_2.htm	EX-32.2	6421
	Complete submission text file	0001214659-15-005948.txt		4147189

Data Files

Seq	Description	Document	Type	Size
8	EXHIBIT 101.INS	anth-20150630.xml	EX-101.INS	596924
9	EXHIBIT 101.SCH	anth-20150630.xsd	EX-101.SCH	35440
10	EXHIBIT 101.CAL	anth-20150630_cal.xml	EX-101.CAL	33498
11	EXHIBIT 101.DEF	anth-20150630_def.xml	EX-101.DEF	133712
12	EXHIBIT 101.LAB	anth-20150630_lab.xml	EX-101.LAB	585474
13	EXHIBIT 101.PRE	anth-20150630_pre.xml	EX-101.PRE	268427

Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545

Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600

Anthera Pharmaceuticals Inc (Filer) CIK: 0001316175 (see all company filings)